Merck introduces first multi-use disposable sterile connectors for biopharma

New Lynx CDR connectors facilitate faster and more economic biopharma fluid management.

"Lynx CDR connectors will change the way pharmaceutical fluids are managed, lowering drug manufacturing costs," said Udit Batra, CEO, Life Science at Merck. "The Lynx CDR connectors set a new standard for sterile fluid connections, dramatically improving ease of use and reliability."

Making simple, reliable, sterile-to-sterile fluid connections is critical to successful biomanufacturing. Previous disposable connector technology allowed users to make only a single sterile connection per device, requiring the use of multiple devices per unit operation. Previous technology also required a dry, non-pressurized flow path during connection and disconnection. These limitations are resource- and cost-intensive when industry standards demand increased productivity and improved efficiency at all stages of the drug manufacturing process. With the Lynx CDR connectors, users can perform faster, more economic fluid management when the flow path is wet and pressurized.

Lynx CDR connectors allow efficient fluid management through sterile connection, disconnection and reconnection giving customers a fail-safe alternative to the time-consuming tube welding processes and costly manifold configurations traditionally used in upstream and downstream processing. The connectors provide efficient fluid management with six sterile connections, disconnections and reconnections from one disposable device.